Maci 3CM x 5CM implant sheets
Ended Awarded
- Contract number
- SPE2DB25FZX97
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $61,539
Award facts
- Contract value 100% obligated
- $61,538.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $61,538.77 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 15, 2025, for MACI 3cm x 5cm implant sheets, with an ultimate completion date of October 6, 2025. This delivery order was issued without a set-aside designation to the woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. MACI (matrix-applied characterized autologous mesenchymal cells) implants are advanced regenerative medicine products used in orthopedic applications, primarily for cartilage repair and restoration in joint injuries.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The parent IDC enables DLA to procure a comprehensive range of pharmaceutical and medical supply products to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering specialized medical products including biologics, specialty pharmaceuticals, and medical consumables to military health systems. The company's federal contracting portfolio demonstrates sustained success in competing for pharmaceutical delivery orders across diverse product categories serving DoD medical requirements.
Quick answers
Who was awarded contract SPE2DB25FZX97?
SPE2DB25FZX97 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FZX97 worth?
The government has obligated $61,539 on SPE2DB25FZX97.
Is contract SPE2DB25FZX97 an order under another contract?
Yes. SPE2DB25FZX97 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX97 competed?
The extent of competition for SPE2DB25FZX97 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award